130 related articles for article (PubMed ID: 22366926)
1. The p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration.
Donini CF; Di Zazzo E; Zuchegna C; Di Domenico M; D'Inzeo S; Nicolussi A; Avvedimento EV; Coppa A; Porcellini A
Int J Oncol; 2012 May; 40(5):1627-35. PubMed ID: 22366926
[TBL] [Abstract][Full Text] [Related]
2. p85 regulatory subunit of PI3K mediates cAMP-PKA and estrogens biological effects on growth and survival.
Cosentino C; Di Domenico M; Porcellini A; Cuozzo C; De Gregorio G; Santillo MR; Agnese S; Di Stasio R; Feliciello A; Migliaccio A; Avvedimento EV
Oncogene; 2007 Mar; 26(14):2095-103. PubMed ID: 17016431
[TBL] [Abstract][Full Text] [Related]
3. The p85 regulatory subunit of PI3K mediates cAMP-PKA and insulin biological effects on MCF-7 cell growth and motility.
Di Zazzo E; Feola A; Zuchegna C; Romano A; Donini CF; Bartollino S; Costagliola C; Frunzio R; Laccetti P; Di Domenico M; Porcellini A
ScientificWorldJournal; 2014; 2014():565839. PubMed ID: 25114970
[TBL] [Abstract][Full Text] [Related]
4. The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals.
De Gregorio G; Coppa A; Cosentino C; Ucci S; Messina S; Nicolussi A; D'Inzeo S; Di Pardo A; Avvedimento EV; Porcellini A
Oncogene; 2007 Mar; 26(14):2039-47. PubMed ID: 17043656
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of p85αPI3KSer83 phosphorylation prevents cell proliferation and invasion in prostate cancer cells.
Feola A; Cimini A; Migliucci F; Iorio R; Zuchegna C; Rothenberger R; Cito L; Porcellini A; Unteregger G; Tombolini V; Giordano A; Di Domenico M
J Cell Biochem; 2013 Sep; 114(9):2114-9. PubMed ID: 23553770
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the laminin beta 1 (LAMB1), retinoic acid receptor beta, and bone morphogenetic protein 2 genes in mutant F9 teratocarcinoma cell lines partially deficient in cyclic AMP-dependent protein kinase activity.
Shen J; Li C; Gudas LJ
Cell Growth Differ; 1997 Dec; 8(12):1297-304. PubMed ID: 9419418
[TBL] [Abstract][Full Text] [Related]
7. Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells.
Naviglio S; Di Gesto D; Illiano F; Chiosi E; Giordano A; Illiano G; Spina A
J Cell Physiol; 2010 Nov; 225(3):801-9. PubMed ID: 20589829
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid induces nuclear FAK translocation and reduces breast cancer cell adhesion through Moesin, FAK, and Paxillin.
Sanchez AM; Shortrede JE; Vargas-Roig LM; Flamini MI
Mol Cell Endocrinol; 2016 Jul; 430():1-11. PubMed ID: 27130522
[TBL] [Abstract][Full Text] [Related]
9. Suppression of nephrin expression by TNF-alpha via interfering with the cAMP-retinoic acid receptor pathway.
Saito Y; Okamura M; Nakajima S; Hayakawa K; Huang T; Yao J; Kitamura M
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1436-44. PubMed ID: 20237236
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol suppresses migration and invasion of malignant breast cells by inactivating Src involving cAMP/PKA and PKCδ signaling pathway.
Dezong G; Zhongbing M; Qinye F; Zhigang Y
J Cancer Res Ther; 2014; 10(4):998-1003. PubMed ID: 25579542
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway.
He JC; Lu TC; Fleet M; Sunamoto M; Husain M; Fang W; Neves S; Chen Y; Shankland S; Iyengar R; Klotman PE
J Am Soc Nephrol; 2007 Jan; 18(1):93-102. PubMed ID: 17182884
[TBL] [Abstract][Full Text] [Related]
12. The AF-1 and AF-2 activating domains of retinoic acid receptor-alpha (RARalpha) and their phosphorylation are differentially involved in parietal endodermal differentiation of F9 cells and retinoid-induced expression of target genes.
Rochette-Egly C; Plassat JL; Taneja R; Chambon P
Mol Endocrinol; 2000 Sep; 14(9):1398-410. PubMed ID: 10976918
[TBL] [Abstract][Full Text] [Related]
13. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain.
Hofmann BT; Jücker M
Cell Signal; 2012 Oct; 24(10):1950-4. PubMed ID: 22735814
[TBL] [Abstract][Full Text] [Related]
14. Cyclic adenosine monophosphate-dependent cell type-specific modulation of mitogenic signaling by retinoids in normal and neoplastic lung cells.
Al-Wadei HA; Schuller HM
Cancer Detect Prev; 2006; 30(5):403-11. PubMed ID: 17067750
[TBL] [Abstract][Full Text] [Related]
15. Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor.
Masiá S; Alvarez S; de Lera AR; Barettino D
Mol Endocrinol; 2007 Oct; 21(10):2391-402. PubMed ID: 17595318
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85alpha Src homology-2 domains.
Lee JY; Chiu YH; Asara J; Cantley LC
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14157-62. PubMed ID: 21825134
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of retinoic acid and 8-chloro-adenosine 3',5'-cyclic monophosphate on the regulation of retinoic acid receptor beta and apoptosis: involvement of mitochondria.
Srivastava RK; Srivastava AR; Cho-Chung YS; Longo DL
Clin Cancer Res; 1999 Jul; 5(7):1892-904. PubMed ID: 10430097
[TBL] [Abstract][Full Text] [Related]
18. Activity of retinoic acid receptor-alpha is directly regulated at its protein kinase A sites in response to follicle-stimulating hormone signaling.
Santos NC; Kim KH
Endocrinology; 2010 May; 151(5):2361-72. PubMed ID: 20215566
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid reduces migration of human breast cancer cells: role of retinoic acid receptor beta.
Flamini MI; Gauna GV; Sottile ML; Nadin BS; Sanchez AM; Vargas-Roig LM
J Cell Mol Med; 2014 Jun; 18(6):1113-23. PubMed ID: 24720764
[TBL] [Abstract][Full Text] [Related]
20. Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation.
Zhao Q; Tao J; Zhu Q; Jia PM; Dou AX; Li X; Cheng F; Waxman S; Chen GQ; Chen SJ; Lanotte M; Chen Z; Tong JH
Leukemia; 2004 Feb; 18(2):285-92. PubMed ID: 14628075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
